Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s):  121-126

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 1
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 2
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 3
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 4
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 5
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Page 6

Download in electronic PDF format for $75

Abstract:  The study of intravenous admixture compatibility is an excellent application of “clinical pharmaceutics.” Clinical pharmaceutics involves the study and application of pharmaceutics and pharmaceutic (physical pharmacy/ chemistry) principles to clinical compounding situations to aid in the evaluation of each intravenous admixture. This series includes compatibility and stability considerations in intravenous admixture compounding. Part 2 of this series of articles discussed many factors that should be considered that may give rise to compatibility concerns, as well as drug sorption issues. In this issue (Part 3), there is a discussion on the methods and techniques that can be used to decrease the occurrence and incidence of incompatibilities, along with some alternate techniques to consider when some approaches do not seem feasible.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, intravenous drug admixtures, compatibility, incompatibilities, reconstitution timing, dilution factor, mixing, sorption, Y sites, concentration, complexation, light sensitivity, freezing, thawing, silicone oil, overfill

Related Categories: PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R
, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007
Pg. 426-432

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
Jan/Feb 2011
Pg. 71

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Return to Top